| Name | Title | Contact Details |
|---|
IEHP, Inland Empire Health Plan, is one of the top 10 largest Medicaid health plans and the largest not-for-profit Medicare-Medicaid plan in the country. With a network of more than 7,300 providers and 2,500 employees, IEHP serves over 1.4 million residents in Riverside and San Bernardino counties who are enrolled in Medicaid or Cal MediConnect Plan (Medicare-Medicaid Plan). Through a dynamic partnership with Providers and community, award-winning service and innovative products, IEHP is fully committed to advocating for our Members and providing them with quality, accessible and wellness-based health care services.
Saint Mary Regional Medical Center is a Apple Valley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Maryland Health Benefit Exchange’s (MHBE) resource site for stakeholders. We continue to work toward the opening of the marketplace in October 2013 of Maryland Health Connection, the state-based health insurance exchange where Maryland residents and small businesses will be able to explore and compare health insurance plans, qualify for cost-sharing reductions and tax credits and complete the enrollment process. The information available through this site supports our work with stakeholders. Meeting schedules and materials, career information, and procurement details are routinely posted. Additionally, the site serves as a resource for the many advisory committees and programs in progress and in development as we collectively work together to establish a health insurance marketplace that best meets the needs of all Marylanders.
Meridian Health Plan is the largest Medicaid HMO in the State of Michigan, providing health care to over 290,000 Medicaid enrollees through a contract with the Michigan Department of Community Health (MDCH). MHP is a physician-owned, physician-managed Medicaid health plan. Its corporate headquarters are located in Detroit, Michigan. Currently, MHP operates in 67 counties. Meridian Health Plan's Michigan Medicaid HMO received an Excellent Accreditation rating from the National Committee for Quality Assurance (NCQA). Excellent is the highest possible Accreditation status from NCQA. To continuously improve the quality of care in a low resource environment
Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.